SCHEMBL6573034

SCHEMBL6573034

FC(F)(F)Oc1ccc(-c2ccc(-c3cc[c]cc3)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.47
NISCH Q9Y2I1 1/20 0.47
SCN5A Q14524 11/20 0.44
AURKA O14965 1/20 0.44
TPX2 Q9ULW0 1/20 0.44
SCN1A P35498 1/20 0.42
SCN2A Q99250 1/20 0.42
MAPT P10636 1/20 0.41
EPHX2 P34913 1/20 0.41
NOTUM Q6P988 1/20 0.41
CA12 O43570 1/20 0.41
CA9 Q16790 1/20 0.41
AKR1C2 P52895 1/20 0.41
AKR1C1 Q04828 1/20 0.41
GRM2 Q14416 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL533257 1.00 KIF11 (0.47) KIF11NISCHSCN5AAURKATPX2
SCHEMBL41971 0.86 MAPT (0.42) KIF11NISCHMAPTEPHX2NOTUM
SCHEMBL28109965 0.84 GPR3 (0.42) KIF11NISCHSCN5AAURKATPX2
SCHEMBL28046390 0.84 MAPT (0.41) KIF11NISCHMAPTEPHX2NOTUM
SCHEMBL28513358 0.84 MAPT (0.41) KIF11NISCHMAPTEPHX2NOTUM
SCHEMBL5542330 0.83 AURKA (0.38) KIF11NISCHSCN5AAURKATPX2
SCHEMBL27629692 0.83 KIF11 (0.34) KIF11NISCHSCN5AAURKATPX2
SCHEMBL920510 0.83 EPHX2 (0.42) KIF11NISCHSCN5AMAPTEPHX2
SCHEMBL28175586 0.80 MAPT (0.42) NISCHAURKATPX2MAPTEPHX2
SCHEMBL22344996 0.79 AURKA (0.45) KIF11NISCHSCN5AAURKATPX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1483242-A1 NITROSODIPHENYLAMINE DERIVATIVES AND THEIR PHARMACEUTICAL USE AGAINST OXIDATIVE STRESS PATHOLOGIES MERCK PATENT GmbH (DE) 2004-12-08 EP disclosed
WO-2003076406-A1 NITROSODIPHENYLAMINE DERIVATIVES AND THEIR PHARMACEUTICAL USE AGAINST OXIDATIVE STRESS PATHOLOGIES MERCK PATENT GMBH (DE) 2003-09-18 WO disclosed